menu
    • menu

    Company profile for SMS Pharmaceuticals

    Farmak works in the development, production and marketing of APIs, Intermediates & Specialties// FDA inspected.

    Virtual Booth

    Contact Supplier

    Evonik

    Virtual Booth

    Contact Supplier

    Biophore is a research-driven global pharmaceutical company focused on niche APIs for the generic industry.

    Virtual Booth

    Contact Supplier

    Quotient Sciences- Molecule to Cure. Fast.

    Virtual Booth

    Contact Supplier

    ChemWerth works in generic API development & supply, non-infringement patent strategy development and regulatory support.

    Virtual Booth

    Contact Supplier

    jdmfs-not-supported-m-2025-04-28

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    ACTIVE PHARMA INGREDIENTS

    INSPECTIONS & REGISTRATIONS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    SMS Pharmaceuticals Ltd. is a global player in API manufacturing having a strong research and manufacturing team supported by state of the art facilities. What started off as a single facility - single product manufacturing company in 1990 grew to be a multi-location group having product list spreading across an array of therapeutic segments. SMS was given the export house status in the year 1997-98. SMS is currently a listed ...
    SMS Pharmaceuticals Ltd. is a global player in API manufacturing having a strong research and manufacturing team supported by state of the art facilities. What started off as a single facility - single product manufacturing company in 1990 grew to be a multi-location group having product list spreading across an array of therapeutic segments. SMS was given the export house status in the year 1997-98. SMS is currently a listed company having ever appreciating international and domestic customer base.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    SMS Pharmaceuticalsindia-flag Flag
    Country
    Country
    India
    Address
    Address
    Regd.off : Plot No:19-III, Road No:71, Jubilee Hills,Opp.Bharatiya Vidya Bhava...
    Telephone
    Telephone
    91 - 40 - 6628 8888
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://smspharma.com/
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Default Event

    CPhI North America

    Not Confirmed

    envelop Contact Supplier

    CPhI North America

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    INTERVIEW #SpeakPharma

    [Sponsored by another company]
    Alchem NicSelect™ grants customers royalty-free access to T-MAX™ tech for 3-in-1 vape satisfaction in flavour-restricted markets

    🎙️Alchem NicSelect™ grants customers royalty-free access to T-MAX™ tech for 3-in-1 vape satisfaction in flavour-restricted markets

    With increasing flavour bans in key markets, vaping brands are facing significant challenges in providing satisfying alternatives to vapers and smokers looking to transition. Recognising this need, Alchem NicSelect™ is making a bold move by offering its key customers royalty-free and unrestricted geographical access to its revolutionary T-MAX™ technology.“At Alchem NicSelect™, we understand the urgency for vaping brands to adapt to new regulations without compromising on satisfaction. By offering royalty-free access to T-MAX™ technology, we empower our customers to provide the closest cigarette-like experience possible, even in markets with strict flavour restrictions,” said Riccardo Santambrogio, Europe Sales Manager.HIGHLIGHTS// offering royalty-free access to T-MAX™ technology/ unrestricted geographical access/ closest cigarette-like experience Addressing the biggest barrier: Nicotine satisfactionOne of the primary reasons many vapers are dissatisfied and smokers struggle to switch to vaping is that traditional nicotine solutions fail to replicate the rapid satisfaction provided by cigarettes. Nicotine replacement therapies (NRTs) and even conventional vaping products often lack the immediate nicotine hit, throat feel, and overall experience that smokers are accustomed to. T-MAX™ solves this problem by engineering a nicotine experience that closely mimics cigarette consumption without relying on flavours.T-MAX™ provides a unique 3-in-1 approach:1. The Speed of a Cigarette – Rapid nicotine delivery and rush within seconds for immediate satisfaction.2. The Power of Nicotine Salts – A stronger perceived nicotine effect without exceeding legal limits (20 mg/ml nicotine limit under the European Tobacco Products Directive). With T-MAX™, 8 mg/ml feels like 20 mg/ml, and 14 mg/ml feels like 40 mg/ml.3. The Throat Hit of Freebase Nicotine – Especially in a flavour-free formulation, the combined ingredients in T-MAX™ deliver an even more satisfying throat feel than expected from nicotine base, much closer to and more familiar with a cigarette throat feel that habitual smokers recognise.HIGHLIGHTS// unique 3-in-1 approach/ rush within seconds/ stronger perceived nicotine effect without exceeding legal limits/ more satisfying throat feel that habitual smokers recogniseNo flavour, but not less satisfyingWhile flavours have traditionally played a role in vaping adoption, market realities are shifting. With flavour bans spreading across regions, brands need solutions that deliver satisfaction without relying on taste. Consumer research has shown that T-MAX™ performs exceptionally well even without added flavours. Since most cigarette smokers do not smoke for the tobacco flavour but rather for the nicotine hit and habitual experience, T-MAX™ provides a viable alternative that aligns with new regulatory landscapes.HIGHLIGHTS// flavour bans spreading across regions/ T-MAX™ performs exceptionally well even without added flavoursEmpowering vape brands with free access to T-MAX™By granting customers royalty-free access to the T-MAX™ technology, Alchem NicSelect™ is removing barriers for vaping brands and original equipment manufacturers (OEMs) looking to adapt to regulatory changes. This open-access approach ensures that manufacturers can integrate T-MAX™ into their product lines without additional costs, allowing them to offer superior nicotine satisfaction in markets where flavours are no longer an option.HIGHLIGHTS// removing barriers for vaping brands and OEMs looking to adapt/ manufacturers can integrate T-MAX™ into product lines without additional costsThe future of vaping in restricted marketsWith T-MAX™, the vaping industry has a powerful tool to retain customers and convert smokers who have struggled with traditional vaping products. By delivering the key elements of cigarette satisfaction — without combustion or flavours — T-MAX™ is set to redefine what a satisfying vape experience means in a post-flavour-ban world.“Our commitment to innovation and accessibility means we are providing our customers with the solutions they need to navigate an evolving regulatory landscape. T-MAX™ allows brands to offer a highly satisfying experience that mimics smoking without relying on flavours. The message is clear: no flavour, but not less satisfying”, added Santambrogio.HIGHLIGHTS// powerful tool to retain customers and convert smokers/ delivering the key elements of cigarette satisfaction without combustion or flavours/ no flavour, but not less satisfying

    Impressions: 228

    subscribeSubscribe

    https://www.pharmacompass.com/speak-pharma/alchem-nicselect-grants-customers-royalty-free-access-to-t-max-tech-for-3-in-1-vape-satisfaction-in-flavour-restricted-markets

    Radio Compass
    06 May 2025
    Share info Share

    DATA COMPILATION #PharmaFlow

    [Sponsored by another company]
    Top Pharma Companies & Drugs in 2024: Merck’s Keytruda maintains top spot as Novo’s semaglutide nips at its heels

    Top Pharma Companies & Drugs in 2024: Merck’s Keytruda maintains top spot as Novo’s semaglutide nips at its heels

    In 2024, Big Pharma players consolidated and maintained their dominance, even as innovation continued to reshape the pharmaceutical landscape. The primary change last year was the meteoric rise of glucagon-like peptide-1 (GLP-1) receptor agonists that treat diabetes and help in weight loss.Amongst drugmakers, Pfizer retained its numero uno spot with an impressive US$ 63.6 billion in prescription drug sales (up 7 percent from US$ 59.56 billion reported in 2023), despite ever-shrinking Comirnaty sales, which settled at US$ 5.35 billion in 2024 (from US$ 11.22 billion in 2023).Merck secured the second position with revenues of US$ 57.4 billion, a growth of 7 percent over 2023. This performance was predominantly fueled by Keytruda, which now accounts for more than half of Merck’s total pharmaceutical revenue. Johnson & Johnson came a close third with US$ 57 billion in prescription drug sales (up from US$ 54.76 billion in 2023).AbbVie held the fourth position with US$ 56.33 billion in sales, achieving 3.7 percent growth despite the ongoing erosion of Humira revenue. This flagship immunology drug saw sales plummet 37.6 percent to approximately US$ 9 billion, a US$ 5.4 billion reduction compared to 2023. Humira’s loss was offset by AbbVie’s newer immunology assets, particularly Skyrizi and Rinvoq, both of which demonstrated exceptional growth trajectories. View Our Interactive Dashboard on Top Drugs in 2024 by Sales (Free Excel Available)European giants Astra, Roche, Novartis, Sanofi round out top 10 list; Novo, Lilly see astounding growthWhile the top four positions were dominated by American drugmakers, European giants dominated the lower half of the top 10 list.AstraZeneca secured the fifth spot with US$ 54.1 billion in sales, thereby posting impressive growth of 18.1 percent over 2023. Roche claimed the sixth position with US$ 50.9 billion in sales while Novartis ranked seventh — with sales of US$ 50.3 billion. Novartis' impressive 10.8 percent sales growth is attributed to its innovative medicines portfolio. Oncology therapies remained a cornerstone for both these Swiss drugmakers.Bristol Myers Squibb (BMS) secured eighth position with revenues of US$ 48.3 billion, representing 7.3 percent growth over the previous year. At US$ 45 billion, Eli Lilly posted 32 percent revenue growth last year. Its GLP-1 drug Mounjaro helped Lilly move up from the tenth in 2023 to the ninth spot last year.Sanofi landed the tenth position with US$ 42.6 billion in sales, propelled largely by the expanding indications of Dupixent. The French multinational has increasingly focused on this immunology blockbuster, while also garnering more sales from its vaccine and rare disease portfolios.Novo Nordisk merits a mention as it posted an incredible 26 percent year-on-year growth. It retained its eleventh spot with US$ 40.25 billion in sales. Novo’s growth was driven almost exclusively by the extraordinary success of its GLP-1 receptor agonist portfolio. View Our Interactive Dashboard on Top Drugs in 2024 by Sales (Free Excel Available)       Merck’s Keytruda retains throne with US$ 29.5 bn in sales, as Novo’s semaglutide nips at its heelsMoving on to drugs, Merck’s Keytruda (pembrolizumab) solidified its position as the world’s top-selling pharmaceutical product with sales exceeding US$ 29.5 billion and year-on-year growth of 17.88 percent (US$ 4.5 billion). This remarkable performance was driven by steady sales growth across more than 40 indications in the US. In 2024 alone, Keytruda secured four new approvals from the US Food and Drug Administration (FDA).However, Novo Nordisk’s semaglutide sales (Ozempic, Wegovy and Rybelsus) gave Keytruda a run for its money. Across the three blockbuster drugs, semaglutide earned the Danish drugmaker around US$ 28 billion — i.e. a year-on-year increase of 38 percent.Novo’s Ozempic (semaglutide) reached over US$ 16.7 billion in sales — a 20 percent increase from 2023. Originally approved in 2017 to improve glycemic control, Ozempic bagged additional approvals in 2020, and in January 2025. It is now approved to reduce the risk of major cardiovascular events, as well as to reduce cardiovascular risk and to lower the likelihood of chronic kidney disease in type 2 diabetes patients.Sales of Wegovy (semaglutide), the other blockbuster GLP-1 drug from Novo, grew by a whopping 85.7 percent to over US$ 8 billion.Sanofi and Regeneron’s Dupixent (dupilumab) secured the number three spot with sales of US$ 13.6 billion, representing an impressive 17.2 percent year-on-year growth. In 2024, Dupixent received three new approvals and one label update. Notably, it became the first-ever biologic medicine approved for patients with chronic obstructive pulmonary disease (COPD). View Our Interactive Dashboard on Top Drugs in 2024 by Sales (Free Excel Available) AbbVie’s post-Humira strategy pays off as Skyrizi surges 51%; Lilly’s Mounjaro posts 124% growthGilead Sciences’ HIV treatment Biktarvy (bictegravir/emtricitabine/tenofovir alafenamide) showed robust growth of 13.27 percent, touching sales of US$ 13.42 billion in 2024 and emerging as the fourth largest selling drug. Biktarvy now commands over 50 percent of the US HIV treatment market. Unlike many other drugs on this list, Biktarvy faces no immediate patent challenges, with key protections expected to remain intact until 2033.BMS and Pfizer’s anticoagulant Eliquis (apixaban) claimed the fifth position with US$ 13.33 billion in sales, representing a 9.21 percent year-on-year increase. AbbVie’s Skyrizi (risankizumab) emerged as one of the fastest-growing assets with a 50.95 percent year-on-year increase, generating US$ 11.71 billion in 2024 sales, thereby surpassing Humira’s (adalimumab) diminished sales.This impressive performance, combined with Rinvoq’s (upadacitinib) growth, has prompted  AbbVie to raise its long-term outlook for these products. The company now expects combined Skyrizi and Rinvoq revenues to exceed US$ 31 billion by 2027, with Skyrizi alone projected to generate over US$ 20 billion.Johnson & Johnson’s Darzalex (daratumumab) claimed the seventh position with US$ 11.67 billion in sales, representing 19.77 percent growth over 2023.Lilly’s Mounjaro (tirzepatide) demonstrated dramatic growth with sales increasing 123.51 percent to US$ 11.54 billion. This performance was complemented by Zepbound (tirzepatide, for weight loss), which contributed US$ 4.9 billion to Lilly’s revenue. By the end of 2024, Mounjaro received FDA approval for a new indication in obstructive sleep apnea (OSA), becoming the first and only prescription medicine for moderate-to-severe OSA in adults with obesity.Stelara (ustekinumab) ranked ninth, bringing J&J sales of US$ 10.36 billion, showing a modest decline of 4.91 percent from its 2023 sales.Vertex’s triple-combination therapy Trikafta (elexacaftor/tezacaftor/ivacaftor) for treating cystic fibrosis rounded out the top ten list with sales of US$ 10.2 billion, up 14 percent from the previous year. View Our Interactive Dashboard on Top Drugs in 2024 by Sales (Free Excel Available) Our viewIn 2024, transformative therapies like GLP-1 receptor agonists drove growth in the pharmaceutical industry. This year, we expect GLP-1 drugs to dethrone Keytruda from the number one spot. Along with novel immunology agents, we expect GLP-1 drugs to realign the pharmaceutical market.  
    subscribeSubscribe
    ExcelExcel Download

    Impressions: 3990

    https://www.pharmacompass.com/radio-compass-blog/top-pharma-companies-drugs-in-2024-merck-s-keytruda-maintains-top-spot-as-novo-s-semaglutide-nips-at-its-heels

    #PharmaFlow by PHARMACOMPASS
    24 Apr 2025
    Share Share

    NEWS #PharmaBuzz

    read-more
    read-more
    SMS Pharmaceuticals Vizag plant gets WHO Geneva prequalification
    SMS Pharmaceuticals Vizag plant gets WHO Geneva prequalification

    03 May 2025

    // INDPHARMAPOST

    https://www.indianpharmapost.com/news/sms-pharmaceuticals-vizag-plant-receives-who-geneva-prequalification-17107

    INDPHARMAPOST
    03 May 2025
    Share Share
    SMS Pharmaceuticals finishes USFDA inspection at Hyderabad site
    SMS Pharmaceuticals finishes USFDA inspection at Hyderabad site

    22 Mar 2025

    // INDPHARMAPOST

    https://www.indianpharmapost.com/drug-approval/sms-pharmaceuticals-completes-usfda-inspection-at-hyderabad-facility-16926

    INDPHARMAPOST
    22 Mar 2025
    Share Share
    SMS Pharma completes USFDA inspection at Hyderabad facility
    SMS Pharma completes USFDA inspection at Hyderabad facility

    22 Mar 2025

    // INDPHARMAPOST

    https://www.indianpharmapost.com/drug-approval/sms-pharmaceuticals-completes-usfda-inspection-at-hyderabad-facility-16926

    INDPHARMAPOST
    22 Mar 2025
    Share Share
    SMS Pharmaceuticals reports robust Q2FY24 operational performance
    SMS Pharmaceuticals reports robust Q2FY24 operational performance

    10 Nov 2023

    // INDIAN PHARMA POST

    https://www.indianpharmapost.com/news/sms-pharmaceuticals-reports-robust-q2fy24-operational-performance-14883

    INDIAN PHARMA POST
    10 Nov 2023
    Share Share
    SMS Pharma Q1 net profit rises 153% at Rs. 23.6 crore
    SMS Pharma Q1 net profit rises 153% at Rs. 23.6 crore

    09 Aug 2021

    // PHARMABIZ

    http://www.pharmabiz.com/NewsDetails.aspx?aid=140678&sid=2

    PHARMABIZ
    09 Aug 2021
    Share Share
    GSK to recall Ranitidine from India after regulator alert
    GSK to recall Ranitidine from India after regulator alert

    26 Sep 2019

    // THEECONOMICTIMES

    https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/gsk-to-recall-ranitidine-from-india-after-regulator-alert/articleshow/71303923.cms

    THEECONOMICTIMES
    26 Sep 2019
    Share Share

    Inspections and registrations

    Upload your audits for free, ask us

    ABOUT THIS PAGE

    Contact SMS Pharmaceuticals and get a quotation

    SMS Pharmaceuticals is a supplier offers 113 products (APIs, Excipients or Intermediates).

    Find a price of Famotidine bulk with DMF, CEP, JDMF offered by SMS Pharmaceuticals

    Find a price of Rizatriptan Benzoate bulk with DMF, CEP, JDMF offered by SMS Pharmaceuticals

    Find a price of Tadalafil bulk with DMF, CEP, JDMF offered by SMS Pharmaceuticals

    Find a price of Lamotrigine bulk with DMF, CEP, WC offered by SMS Pharmaceuticals

    Find a price of Levetiracetam bulk with DMF, CEP, WC offered by SMS Pharmaceuticals

    Find a price of Solifenacin Succinate bulk with DMF, CEP, WC offered by SMS Pharmaceuticals

    Find a price of Sumatriptan bulk with CEP, JDMF offered by SMS Pharmaceuticals

    Find a price of Vardenafil Hydrochloride bulk with DMF, CEP, WC offered by SMS Pharmaceuticals

    Find a price of Aripiprazole bulk with CEP, WC offered by SMS Pharmaceuticals

    Find a price of Itraconazole bulk with DMF, CEP offered by SMS Pharmaceuticals

    Find a price of Ondansetron Hydrochloride bulk with DMF, CEP offered by SMS Pharmaceuticals

    Find a price of Pantoprazole Sodium bulk with CEP, WC offered by SMS Pharmaceuticals

    Find a price of Ranitidine Hydrochloride bulk with CEP, WC offered by SMS Pharmaceuticals

    Find a price of Apixaban bulk with DMF, WC offered by SMS Pharmaceuticals

    Find a price of Efavirenz bulk with DMF, WC offered by SMS Pharmaceuticals

    Find a price of Famotidine bulk with CEP, JDMF offered by SMS Pharmaceuticals

    Find a price of Ibuprofen bulk with DMF, CEP offered by SMS Pharmaceuticals

    Find a price of Pantoprazole Sodium bulk with DMF, CEP offered by SMS Pharmaceuticals

    Find a price of Sildenafil Citrate bulk with CEP offered by SMS Pharmaceuticals

    Find a price of Almotriptan Malate bulk with DMF offered by SMS Pharmaceuticals

    Find a price of Imidapril Hydrochloride bulk with DMF offered by SMS Pharmaceuticals

    Find a price of Rosiglitazone Maleate bulk with WC offered by SMS Pharmaceuticals

    Find a price of Zolmitriptan bulk with DMF offered by SMS Pharmaceuticals

    Find a price of Aripiprazole bulk with DMF offered by SMS Pharmaceuticals

    Find a price of Clozapine bulk with DMF offered by SMS Pharmaceuticals

    Find a price of Eletriptan Hydrobromide Monohydrate bulk with DMF offered by SMS Pharmaceuticals

    Find a price of Escitalopram Oxalate bulk with DMF offered by SMS Pharmaceuticals

    Find a price of Hydroxychloroquine Sulphate bulk with DMF offered by SMS Pharmaceuticals

    Find a price of Ibuprofen Sodium bulk with DMF offered by SMS Pharmaceuticals

    Find a price of Lamivudine bulk with DMF offered by SMS Pharmaceuticals

    Find a price of Lanoconazole bulk with JDMF offered by SMS Pharmaceuticals

    Find a price of Lopinavir bulk with WC offered by SMS Pharmaceuticals

    Find a price of Luliconazole bulk with WC offered by SMS Pharmaceuticals

    Find a price of Molnupiravir bulk with DMF offered by SMS Pharmaceuticals

    Find a price of Paliperidone Palmitate bulk with WC offered by SMS Pharmaceuticals

    Find a price of Penciclovir bulk with WC offered by SMS Pharmaceuticals

    Find a price of Penciclovir Sodium bulk with DMF offered by SMS Pharmaceuticals

    Find a price of Pirfenidone bulk with DMF offered by SMS Pharmaceuticals

    Find a price of Ramipril bulk offered by SMS Pharmaceuticals

    Find a price of Ranitidine Hydrochloride bulk with DMF offered by SMS Pharmaceuticals

    Find a price of Ranitidine Hydrochloride bulk offered by SMS Pharmaceuticals

    Find a price of Ranolazine bulk with WC offered by SMS Pharmaceuticals

    Find a price of Rivaroxaban bulk with DMF offered by SMS Pharmaceuticals

    Find a price of Rosiglitazone Maleate bulk with DMF offered by SMS Pharmaceuticals

    Find a price of Sildenafil Citrate bulk with DMF offered by SMS Pharmaceuticals

    Find a price of Sitagliptin Hydrochloride bulk with WC offered by SMS Pharmaceuticals

    Find a price of Sumatriptan bulk with DMF offered by SMS Pharmaceuticals

    Find a price of Sumatriptan bulk offered by SMS Pharmaceuticals

    Find a price of Tenofovir Disoproxil Fumarate bulk with WC offered by SMS Pharmaceuticals

    Find a price of Vildagliptin bulk with WC offered by SMS Pharmaceuticals

    Find a price of Apixaban bulk offered by SMS Pharmaceuticals

    Find a price of Eletriptan Hydrobromide bulk offered by SMS Pharmaceuticals

    Find a price of Itraconazole bulk offered by SMS Pharmaceuticals

    Find a price of Lansoprazole bulk offered by SMS Pharmaceuticals

    Find a price of Nicotine bulk offered by SMS Pharmaceuticals

    Find a price of Vardenafil Hydrochloride bulk offered by SMS Pharmaceuticals

    Find a price of Aciclovir bulk offered by SMS Pharmaceuticals

    Find a price of Amlodipine Besylate bulk offered by SMS Pharmaceuticals

    Find a price of Atorvastatin bulk offered by SMS Pharmaceuticals

    Find a price of Bedaquiline bulk offered by SMS Pharmaceuticals

    Find a price of Bempedoic Acid bulk offered by SMS Pharmaceuticals

    Find a price of Cabergoline bulk offered by SMS Pharmaceuticals

    Find a price of Carbamazepine bulk offered by SMS Pharmaceuticals

    Find a price of Cariprazine Hydrochloride bulk offered by SMS Pharmaceuticals

    Find a price of Cenobamate bulk offered by SMS Pharmaceuticals

    Find a price of Citalopram bulk offered by SMS Pharmaceuticals

    Find a price of Clemastine bulk offered by SMS Pharmaceuticals

    Find a price of Dapagliflozin bulk offered by SMS Pharmaceuticals

    Find a price of Dapagliflozin Propanediol Monohydrate bulk offered by SMS Pharmaceuticals

    Find a price of Daridorexant Hydrochloride bulk offered by SMS Pharmaceuticals

    Find a price of Deferasirox bulk offered by SMS Pharmaceuticals

    Find a price of Dexmedetomidine Hydrochloride bulk offered by SMS Pharmaceuticals

    Find a price of Dolutegravir Sodium bulk offered by SMS Pharmaceuticals

    Find a price of Droxidopa bulk offered by SMS Pharmaceuticals

    Find a price of Elagolix Sodium bulk offered by SMS Pharmaceuticals

    Find a price of Elexacaftor bulk offered by SMS Pharmaceuticals

    Find a price of Empagliflozin bulk offered by SMS Pharmaceuticals

    Find a price of Eslicarbazepine Acetate bulk offered by SMS Pharmaceuticals

    Find a price of Etilevodopa bulk offered by SMS Pharmaceuticals

    Find a price of Fenoprofen Calcium bulk offered by SMS Pharmaceuticals

    Find a price of Fosfomycin Trometamol bulk offered by SMS Pharmaceuticals

    Find a price of Ibuprofen bulk offered by SMS Pharmaceuticals

    Find a price of Ibuprofen Lysinate bulk offered by SMS Pharmaceuticals

    Find a price of Isavuconazonium Sulfate bulk offered by SMS Pharmaceuticals

    Find a price of Isocarboxazid bulk offered by SMS Pharmaceuticals

    Find a price of Lacosamide bulk offered by SMS Pharmaceuticals

    Find a price of Lasmiditan bulk offered by SMS Pharmaceuticals

    Find a price of Loxoprofen Sodium bulk offered by SMS Pharmaceuticals

    Find a price of Macitentan bulk offered by SMS Pharmaceuticals

    Find a price of Mavacamten bulk offered by SMS Pharmaceuticals

    Find a price of Melperone bulk offered by SMS Pharmaceuticals

    Find a price of Mesalazine bulk offered by SMS Pharmaceuticals

    Find a price of Metaraminol Bitartrate bulk offered by SMS Pharmaceuticals

    Find a price of Mirabegron bulk offered by SMS Pharmaceuticals

    Find a price of Mitapivat bulk offered by SMS Pharmaceuticals

    Find a price of Nirmatrelvir bulk offered by SMS Pharmaceuticals

    Find a price of Oxcarbazepine bulk offered by SMS Pharmaceuticals

    Find a price of Paliperidone bulk offered by SMS Pharmaceuticals

    Find a price of Peramivir bulk offered by SMS Pharmaceuticals

    Find a price of Perampanel bulk offered by SMS Pharmaceuticals

    Find a price of Pimavanserin Tartrate bulk offered by SMS Pharmaceuticals

    Find a price of Quetiapine Hemifumarate bulk offered by SMS Pharmaceuticals

    Find a price of Ranitidine bulk offered by SMS Pharmaceuticals

    Find a price of Rilpivirine Hydrochloride bulk offered by SMS Pharmaceuticals

    Find a price of Sitagliptin Phosphate bulk offered by SMS Pharmaceuticals

    Find a price of Sodium Gluconate bulk offered by SMS Pharmaceuticals

    Find a price of Stiripentol bulk offered by SMS Pharmaceuticals

    Find a price of Suvorexant bulk offered by SMS Pharmaceuticals

    Find a price of Tadalafil bulk offered by SMS Pharmaceuticals

    Find a price of Triclabendazole bulk offered by SMS Pharmaceuticals

    Find a price of Valacyclovir Hydrochloride bulk offered by SMS Pharmaceuticals

    Find a price of Vibegron bulk offered by SMS Pharmaceuticals

    Find a price of Viloxazine Hydrochloride bulk offered by SMS Pharmaceuticals

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search